Affordable Access

deepdyve-link
Publisher Website

Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism.

Authors
  • Jamaluddin, Ema J
  • Gafor, Abdul Halim Abdul
  • Yean, Loo Chee
  • Cader, Rizna
  • Mohd, Rozita
  • Kong, Norella C T
  • Shah, Shamsul Azhar
Type
Published Article
Journal
Clinical and experimental nephrology
Publication Date
Jun 01, 2014
Volume
18
Issue
3
Pages
507–514
Identifiers
DOI: 10.1007/s10157-013-0844-2
PMID: 23903802
Source
Medline
License
Unknown

Abstract

Both oral paricalcitol and calcitriol were equally efficacious in reducing serum iPTH but were associated with significantly higher serum calcium. Serum Ca × P product increased in the paricalcitol group and decreased in the calcitriol group. Serum hsCRP level and PFT were not affected by either treatment. A larger randomized controlled trial is indicated to confirm these initial findings.

Report this publication

Statistics

Seen <100 times